April 2012 Issue of ONA
In the News
In response to critical shortages, the FDA has issued draft guidance on mandatory and voluntary notifications to the agency.
New guidelines call for screening at age 50 years in average-risk adults and age 40 years or 10 years younger than age of diagnosis in ...
CT colonography accurately detects cancer and precancerous polyps in persons aged 65 years and older.
The Agency for Healthcare Research and Quality (AHRQ) released Statistical Brief #125 Cancer Hospitalizations for Adults, 2009.
A new service has helped reduce the number of women who need additional surgery after an initial resection for breast cancer.
Scientists have discovered that the Abraxas gene may advance the mission of BRCA1 and may even act on its own to help breast cancer develop.
A large UK study found a wide variation between cancer types in patients who had visited their general practitioner 3 or more times before cancer ...
Physicians have changed management recommendations for almost half of patients with known or suspected brain tumors after PET/CT findings.
For Your Patient
Meditation can help relieve stress in cancer patients. The following article details several types of meditation and includes related clinical trials.
Cancer patients may wish to explore acupuncture or other integrative care options. The following article details several options and provides related resources.
This review describes the four major groups of leukemia, plus diagnostic tests and treatment regimens for each group.
The Total Nurse
These tips and resources can help oncology nurses and other clinicians ease the burden of caring for both parents and children.
New research is showing that sequence and timing have significant impact on the efficacy of therapeutic regimens that include bevacizumab.
Issues in Cancer Survivorship
A group at the Mayo Clinic, Jacksonville, Florida, uses modern technology to provide survivorship care and counseling to patients.
Radiation and Your Patient
Researchers are investigating the use of genomics to achieve better cure rates with less morbidity in patients undergoing radiation treatment.
Nurses anticipate a patient's need for pain meds. But understanding why a patient has no need for them may be difficult.
From Cancer Care
The variety of options available to help patients manage their pain can improve quality of life during and after cancer treatment.
Ask a Pharmacist
What is the risk for endometrial cancer in a patient taking tamoxifen to reduce recurrence of ER/PR positive breast cancer after treatment?
What specific visual changes are associated with the new drug crizotinib and what causes them?
The Total Patient
Prognosis for patients with esophageal cancer is poor. Care options focus on minimizing discomfort and maintaining nutritional status.
- PMPS: A Common Late Effect of Surgery and Radiation for Breast Cancer
- Breast Cancer Tumors Often a Composite of Tumor Types, Enhancing Treatment Resistance
- Physical Activity May Reduce Mortality by 44% in Patients With Breast Cancer
- Hormone Receptor Test Results in DCIS Core Needle Biopsy Not Used, Not Needed
- Daratumumab Plus Len-Dex an Encouraging Combo for Multiple Myeloma
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Triple-Drug Therapy Produces Response in Triple-Negative Breast Cancer, Mouse Study Shows
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Study Supports Increased Role for Surgery in Multimodality Therapy for Early Stage SCLC
- Supportive Care Needs Assessed in Localized Cutaneous Melanoma
- Recently Discovered microRNA Controls Response to Oxaliplatin in Colorectal Cancer
- Nurses Are Key to Referrals to Inpatient Integrative Medicine Services
- Daratumumab Combo Improves PFS in Relapsed/Refractory Myeloma
- Poor Compliance to Adjuvant Chemo Linked to Poorer Survival in Rectal Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|